BioPharmica Limited - July 2
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 29 June, 2004 - 22:00
BioPharmica Limited - July 2
Proposed code: BPH
Issue price: $0.20
Principal activities: Biomedical commercialisation business partnering univerisities, medical institutes, companies and hospitals.
Corporate: David Breeze (chairman and managing director); Seng Yap (non-executive director); and Charles Murphy (executive director).
www.biopharmica.com.au
(08) 9244 9631
BioPharmica plans to raise $4.5 million from a 20 cent a share offer that was scheduled to close on June 25. The offer is not underwritten